- Report
- March 2024
- 329 Pages
Global
From €5252EUR$5,972USD£4,350GBP
- Report
- October 2023
- 428 Pages
Global
From €5252EUR$5,972USD£4,350GBP
- Report
- March 2022
- 518 Pages
Global
From €4828EUR$5,491USD£3,999GBP
- Report
- May 2022
- 100 Pages
Global
From €774EUR$850USD£663GBP
€1547EUR$1,700USD£1,326GBP
- Report
- May 2022
- 95 Pages
Global
From €728EUR$800USD£624GBP
€1456EUR$1,600USD£1,248GBP
- Report
- May 2022
- 113 Pages
Global
From €819EUR$900USD£702GBP
€1638EUR$1,800USD£1,404GBP
- Report
- September 2023
- 73 Pages
United States
From €2048EUR$2,250USD£1,755GBP
€4095EUR$4,500USD£3,511GBP
- Report
- April 2024
- 200 Pages
Global
From €3800EUR$4,175USD£3,257GBP
- Report
- February 2024
- 158 Pages
Global
From €4232EUR$4,650USD£3,628GBP
- Report
- December 2023
- 123 Pages
Global
From €4232EUR$4,650USD£3,628GBP
- Report
- November 2021
- 123 Pages
Global
From €2503EUR$2,750USD£2,146GBP
€5006EUR$5,500USD£4,291GBP
- Report
- June 2023
- 311 Pages
Global
From €5051EUR$5,550USD£4,330GBP
- Report
- October 2021
- 199 Pages
Global
From €5051EUR$5,550USD£4,330GBP
- Report
- February 2024
- 237 Pages
Global
From €4505EUR$4,950USD£3,862GBP
- Report
- December 2023
- 445 Pages
Global
From €4505EUR$4,950USD£3,862GBP
- Report
- November 2022
- 41 Pages
Global
From €3185EUR$3,500USD£2,731GBP
- Report
- March 2019
- 170 Pages
Global
From €1251EUR$1,375USD£1,073GBP
€2503EUR$2,750USD£2,146GBP
- Report
- December 2018
- 259 Pages
Global
From €1251EUR$1,375USD£1,073GBP
€2503EUR$2,750USD£2,146GBP
- Report
- April 2022
- 300 Pages
Asia Pacific
From €4505EUR$4,950USD£3,862GBP
- Report
- February 2022
- 232 Pages
Global
From €4505EUR$4,950USD£3,862GBP

The Infusions and Injectables market is a segment of the pharmaceutical industry that focuses on the production and distribution of drugs that are administered through intravenous (IV) or intramuscular (IM) injections. These drugs are used to treat a variety of medical conditions, including cancer, diabetes, and autoimmune diseases. The market is highly competitive, with a number of large pharmaceutical companies vying for market share.
The market is divided into two main segments: branded and generic drugs. Branded drugs are typically more expensive than generic drugs, but they are often more effective and have fewer side effects. Generic drugs are typically cheaper, but they may not be as effective or have as many side effects.
Some of the major players in the Infusions and Injectables market include Pfizer, Merck, Novartis, Sanofi, and Johnson & Johnson. These companies are responsible for the production and distribution of a wide range of drugs, including cancer treatments, diabetes medications, and autoimmune therapies. Show Less Read more